Thalassemia and malignancy: An emerging concern?

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Thalassemias are inherited blood disorders affecting hemoglobin production.
• Advances in transfusion and iron chelation therapy have significantly increased patient lifespan.
• Increased longevity in thalassemia patients has led to new health challenges, including malignancies.

Purpose of the Study:

• To review the types of solid and hematologic malignancies observed in thalassemia patients.
• To explore potential predisposing factors and underlying mechanisms for these cancers.
• To provide a comprehensive overview for clinicians and researchers.

Main Methods:

• Literature review of studies on thalassemia and malignancy.
• Analysis of reported cases and epidemiological data.
• Synthesis of information on genetic and environmental risk factors.

Main Results:

• Thalassemia patients exhibit an increased incidence of various solid tumors and hematologic malignancies.
• Specific genetic mutations and chronic inflammation may predispose patients to cancer.
• Iron overload and frequent transfusions are potential contributing factors.

Conclusions:

• Long-term survival in thalassemia necessitates vigilant monitoring for cancer development.
• Understanding the mechanisms of malignancy in thalassemia is crucial for prevention and early detection.
• Further research is needed to develop targeted strategies for cancer risk reduction in this population.